1. Dennehy PH. Rotavirus Infection: A Disease of the Past? Infectious Disease Clinics of North America 2015; 29: 617-635.
2. Simpson E, Wittet S, Bonilla J, Gamazina K, Cooley L, Winkler JL. Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing
countrie. BMC Public Health 2007; 7: 281.
3. Dubovi EJ, MacLachlan NJ. In: Fenner’s Veterinary Virology. 4th Edition. Academic Press, Boston: ABD; 2010.
4. Light JS, Hodes HL (1943). Studies on Epidemic Diarrhea of the New-born: Isolation of a Filtrable Agent Causing Diarrhea in Calves. American Journal of Public Health and the Nation’s
Health 1943; 33: 1451-1454.
5. Woode GN, Bridger JC, Jones JM, et al. Morphological and antigenic relationships between viruses (rotaviruses) from acute gastroenteritis in children, calves, piglets, mice, and foals. Infection
and Immunity 1976; 14: 804-810.
6. Flewett TH, Woode GN. The rotaviruses. Archives of Virology 1978; 57: 1-23.
7. Ward RL, Bernstein DI. Rotarix: a rotavirus vaccine for the world. Clinical Infectious Diseases 2009; 48: 222-228.
8. Prasad BV, Chiu W. Structure of Rotavirus. In:Ramig RF, eds. Rotaviruses: Current Topics in Microbiology and Immunology. Springer, New York: ABD; 1994.
9. Kirkwood CD. Genetic and antigenic diversity of human rotaviruses: potential impact on vaccination program. The Journal of Infectious Diseases 2010; 202: 43-48.
10. Beards GM, Desselberger U, Flewett TH. Temporal and geographical distributions of human rotavirus serotypes, 1983 to 1988. Journal of Clinical Microbiology 1989; 27: 2827-2833.
11. Gray J, Desselberger U. Rotaviruses: methods and protocols. Humana Press, Totowa: NJ, ABD; 2000.
12. Patton JT. Structure and function of the rotavirus RNA-binding proteins. The Journal of General Virology 1995; 76: 2633-2644.
13. Patton JT. Rotavirus RNA Replication and Gene Expression. Gastroenteritis Viruses. Novartis Foundation Symposium 2001; 238: 64-81.
14. Sharma S, Hagbom M, Svensson L, Nordgren J.The Impact of Human Genetic Polymorphisms on Rotavirus Susceptibility, Epidemiology, and Vaccine Take. Viruses 2020; 12: 324.
15. Taraporewala ZF, Patton JT. Nonstructural proteins involved in genome packaging and replication of rotaviruses and other members of the Reoviridae. Virus Research 2004; 1.
16. Ruiz MC, Leon T, Diaz Y, Michelangeli F. Molecular biology of rotavirus entry and replication. The Scientific World Journal 2009; 9: 1476-1497.
17. Dennehy PH. Transmission of rotavirus and other enteric pathogens in the home. Pediatric Infectious Disease Journal 2000; 19: 103-105.
18. Simpson E, Wittet S, Bonilla J, Gamazina K, Cooley L, Winkler JL. Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing
countries. BMC Public Health 2007; 7: 281.
19. Janko MM, Joffe J, Michael D, et al. Cost-effectiveness of rotavirus vaccination in children under five years of age in 195 countries: A meta-regression analysis. Vaccine 2022; 40: 3903-3917.
20. Leshem E, Moritz RE, Curns AT, et al. Rotavirus vaccines and health care utilization for diarrhea in the United States (2007–2011). Pediatrics 2014; 134: 15-23.
21. Koopmans M, Brown D. Seasonality and diversity of Group A rotaviruses in Europe. Acta Paediatrica 1999; 88: 14-19.
22. Linhares AC, Pinheiro FP, Freitas RB, Gabbay YB, Shirley JA, Beards GM. “An outbreak of rotavirus diarrhea among a non-immune, isolated South American Indian community”. American
Journal of Epidemiology 1981; 113: 703-710.
23. Bucardo F, Karlsson B, Nordgren J, et al. Mutated G4P 8 rotavirus associated with a nationwide outbreak of gastroenteritis in Nicaragua in 2005. Journal of Clinical Microbiology 2007; 45:
990-997.
24. Parashar UD, Johnson H, Steele AD, Tate JE. Health Impact of Rotavirus Vaccination in Developing Countries: Progress and Way Forward. Clinical Infectious Diseases 2016; 62: 91-95.
25. Moon S, Humphrey CD, Kim JS, et al. First detection of group C rotavirus in children with acute gastroenteritis in South Korea”. Clinical Microbiology and Infection 2011; 17: 244-247.
26. Dóró R, Farkas SL, Martella V, Bányai K. Zoonotic transmission of rotavirus: surveillance and control. Expert Review of Anti-infective Therapy 2015; 13: 1337-1350.
27. Ramig RF. Pathogenesis of intestinal and systemic rotavirus infection. Journal of Virology 2004; 78: 10213-10220.
28. Ward R. Mechanisms of protection against rotavirus infection and disease. The Pediatric Infectious Disease Journal 2009; 28: 57-S59.
29. Holloway G, Coulson BS. Innate cellular responses to rotavirus infection”. The Journal of General Virology 2013; 94: 1151-1160.
30. Offit PA. Gastroenteritis viruses. Wiley, New York: ABD; 2001.
31. Anderson EJ, Weber SG. Rotavirus infection in adults. The Lancet Infectious Diseases 2004; 4: 91-99.
32. Patel M, Glass RI, Jiang B, Santosham M, Lopman B, Parashar U. A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. The Journal
of Infectious Diseases 2013; 208: 284-294.
33. Patel MM, Tate JE, Selvarangan R, et al. Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination. The Pediatric Infectious Disease
Journal 2007; 26: 914-919.
34. Fischer TK, Gentsch JR. Rotavirus typing methods and algorithms. Reviews in Medical Virology 2004; 14: 71-82.
35. The Pediatric ROTavirus European CommitTee (PROTECT).The paediatric burden of rotavirus disease in Europe. Epidemiology and Infection 2006; 134: 908-916.
36. Guarino A, Ashkenazi S, Gendrel D, Lo Vecchio A, Shamir R, Szajewska H. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric
Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. Journal of Pediatric Gastroenterology and Nutrition 2014; 59:
132-152.
37. Ahmadi E, Alizadeh-Navaei R, Rezai MS. Efficacy of probiotic use in acute rotavirus diarrhea in children: A systematic review and meta-analysis. Caspian Journal of Internal Medicine 2015;
6: 187-195.
38. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. MMWR Recommenda-
tions and Reports 1999; 48: 1-20.
39. Bines J. Intussusception and rotavirus vaccines. Vaccine 2006; 24: 3772-3776.
40. World Health Organization. Rotavirus vaccines: an update. Weekly Epidemiological Record 2009; 51–52: 533-540.
41. Patel MM, Parashar UD. Real World Impact of Rotavirus Vaccination. Pediatric Infectious Disease Journal 2011; 30: 1-5.
42. Karafillakis E, Hassounah S, Atchison C. Effectiveness and impact of rotavirus vaccines in Europe, 2006–2014. Vaccine 2015; 33: 2097-2107.
NOROVİRÜS
KAYNAKLAR
1. https://www.nhs.uk/norovirus (vomiting bug)/2017.
2. https://www.cdc.gov/norovirus symptoms/2016.
3. Kapikian AZ. Overview of viral gastroenteritis. Viral Gastroenteritis. Archives of Virology 1996; 12: 7–19.
4. Büchen-Osmond C. ICTVdB Management. 00.012.0.03. Norovirus. In: ICTVdB—The Universal Virus Database, V.4. Columbia University, New York; 2006.
5. Appleton H. Small Round Viruses: Classification and Role in Food-Borne Infections. Ciba Foundation Symposium 128–Novel Diarrhoea Viruses. 1987; 128: 108–25.
6. Parashar U, Quiroz ES, Mounts AW, et al. Norwalk-Like Viruses: Public Health Consequences and Outbreak Management. MMWR Recommendations and Reports 2001; 50: 1–18.
7. Prasad BV, Crawford S, Lawton JA, Pesavento J, Hardy M, Estes MK. Structural Studies on Gastroenteritis Viruses. Novartis Foundation Symposia. 2001; 238: 26-46.
8. Clarke IN, Lambden PR. Organization and expression of calicivirus genes”. The Journal of Infectious Diseases 2000; 181: 309-16.
9. Tan M, Hegde RS, Jiang X. The P Domain of Norovirus Capsid Protein Forms Dimer and Binds to Histo-Blood Group Antigen Receptors. J. Virol. 2004; 78: 6233–42.
10. https://www.ictv.global/ Family: Caliciviridae/2019.
11. https://www.viralzone/ ExPASy/2015.
12. Tsimpidis M, Bachoumis G, Mimouli K, et al. T-RECs: rapid and large-scale detection of recombination events among different evolutionary lineages of viral genomes. BMC Bioinformatics
2017; 18: 13.
13. Atmar RL, Opekun AR, Gilger MA, et al. Norwalk Virus Shedding after Experimental Human Infection. Emerg. Infect. Dis. 2008; 14: 1553–7.
14. D’Souza DH, Sair A, Williams K, et al. Persistence of caliciviruses on environmental surfaces and their transfer to food”. International Journal of Food Microbiology 2006; 108: 84–91.
15. Marks PJ, Vipond IB, Carlisle D, Deakin D, Fey RE, Caul EO. Evidence for airborne transmission of Norwalk-like virus (NLV) in a hotel restaurant. Epidemiol Infect 2000; 124: 481–487.
16. Heijne JC, Teunis P, Morroy G, et al. Enhanced Hygiene Measures and Norovirus Transmission during an Outbreak”. Emerg. Infect. Dis. 2009; 15: 24–30.
17. Government of Canada. Safe Internal Cooking Temperatures Chart. 27 Aralık 2017.
18. HPA. Shellfish consumption and the risk of norovirus infection. 14 Temmuz 2014.
19. Sherwood D. How a Chilean raspberry scam dodged food safety controls from China to Canada. Reuters. 10 Ekim 2020.
20. Cruise ships are seeing the highest number of norovirus outbreaks in a decade. Deseret News. 15 Temmuz 2023.
21. https://www.cdc.gov/Norovirus Worldwide/15 Aralık 2017.
22. Nguyen GT, Phan K, Teng I, Pu J, Watanabe T. A systematic review and meta-analysis of the prevalence of norovirus in cases of gastroenteritis in developing countries. Medicine 2017; 96:
8139.
23. https://www.cdc.gov/Vessel Sanitation Program – Outbreak Updates for International Cruise Ships/10 Mayıs 2016.
24. Public Health Laboratory Network. Government Department of Health and Ageing. Norovirus Laboratory Case Definition (LCD); 2008.
25. Vinjé J, Green J, Lewis DC, Gallimore CI, Brown DW, Koopmans MP. Genetic polymorphism across regions of the three open reading frames of “Norwalk-like viruses”. Arch. Virol.2000; 145:
223–41.
26. Carlsson B, Kindberg E, Buesa J, et al. The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 norovirus infection”. PLOS ONE 2009; 4:
5593.
27. Graziano VR, Jin W, Wilen CB. Norovirus Attachment and Entry. Viruses 2019; 11: 495.
28. McCartney SA, Thackray LB, Gitlin L, et al. MDA-5 Recognition of a Murine Norovirus. PLOS Pathog. 2008; 4: 1000108.
29. Hall AJ, Lopman BA, Payne DC, et al. Norovirus disease in the United States. Emerging Infectious Diseases 2013; 19: 1198–205.
30. Marshall JA, Bruggink LD. Laboratory diagnosis of norovirus. Clin. Lab. 2006; 52: 571–81.
31. https://www.cdc.gov/norovirus/index.html. Erişim tarihi:14 Aralık 2023.
32. Public Health Agency of Canada. Diseases Under National Surveillance. 17 Eylül 2003.
33. US Environmental Protection Agency. List G: EPA Registered Hospital Disinfectants Effective Against Norovirus (Norwalk-like virus). 28 September 2015.
34. Sherwood J, Mendelman PM, Lloyd E, et al. Efficacy of an intramuscular bivalent norovirus GI.1/GII.4 virus-like particle vaccine candidate in healthy US adults. Vaccine 2020; 38: 6442–6